The Pathophysiological Role of Protein Phosphatase 2A (PP2A) in metabolic Syndrome
The Pathophysiological Role of Protein Phosphatase 2A (PP2A) in metabolic Syndrome
批准号:
17590927
负责人:
UGI Satoshi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
我们发现,棕榈酸酯和C2-神经酰胺的预孵育通过抑制3T3-L1脂肪细胞的Akt而诱导胰岛素抵抗。棕榈酸酯的抑制作用可被阻断。麦角菌素,神经酰胺合成抑制剂。肉豆蔻酸盐或油酸盐不是神经酰胺的前体,不会引起胰岛素抵抗。我们还发现PP2A活性被棕榈酸刺激,PP2A抑制剂冈田酸可阻断棕榈酸对Akt的抑制作用。这些结果表明,棕榈酸酯通过激活脂肪细胞内神经酰胺的从头合成来激活Akt,从而抑制Akt。另一方面,棕榈酸酯和C2-神经酰胺对FAO大鼠肝癌细胞Akt的抑制作用与对3T3-L1脂肪细胞的抑制作用相同,但这种抑制作用并不伴随PP2A的激活。为了支持这一结果,冈田酸或豆蔻菌素不能阻断棕榈酸诱导的Akt抑制。这些结果表明,PP2A的激活或神经酰胺的合成都不参与棕榈酸诱导的FAO细胞的胰岛素抵抗。最后,在L6心肌细胞中,棕榈酸酯和C2-神经酰胺对Akt的抑制作用被冈田酸部分阻断。肉豆蔻酸盐不能抑制AKT,肉豆蔻菌素部分阻断棕榈酸酯的S效应。总而言之,棕榈酸酯通过不同的细胞类型通过不同的机制导致胰岛素抵抗。
英文摘要
We have found that preincubation of palmitate and C2-ceramide induced insulin resistance through inhibiting Akt in 3T3-L1 adipocytes. The inhibitory effect of palmitate was blocked by. myriocin, ceramide synthesis inhibitor. Myristate or oleate, which are not the precursor of ceramide, did not cause insulin resistance. We also found that PP2A activity was stimulated by palmitate and okadaic acid, PP2A inhibitor, blocked palmitate-induced Akt inhibition. These results suggest that palmitate inhibits Akt through activating Akt by de novo synthesis of ceramide in the cells in adipocytes.On the other hand, although, palmitate and C2-ceramide inhibited Akt in Fao rat hepatoma cells as same as in 3T3-L1 adipocytes, the inhibition was not accompanied by PP2A activation. In support of this result, okadaic acid or myriocin did not block palmitate-induced Akt inhibition. These results suggest that either PP2A activation or ceramide synthesis is not involved in palmitate-induced insulin resistance in Fao cells.Finally, in L6 myocytes, palmitate and C2-ceramide induced Akt inhibition was partially blocked okadaic acid. Myristate did not inhibit Akt and myriocin partially blocked palmitate' s effect. In conclusion, palmitate causes insulin resistance through different mechanisms among different cell types
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1210/en.2005-1304
发表时间:
2006-04-01
期刊:
ENDOCRINOLOGY
影响因子:
4.8
作者:
[Tao, Y, Maegawa, H, Kashiwagi, A]
通讯作者:
Kashiwagi, A
「研究成果報告書概要(欧文)」より
摘自《研究结果报告摘要(欧洲)》
DOI:
--
发表时间:
2006
期刊:
Seibutsu Butsuri 46(1)
影响因子:
--
作者:
[Yasushi Shigeri, Keiko Shimamoto]
通讯作者:
Keiko Shimamoto
CCDC3 is specifically upregulated in omental adipose tissue in subjects with abdominal obesity
-
批准号:23591304
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:UGI Satoshi
-
依托单位:
The role of AP2β, the molecule which leads to adipocyte hypertrophy, in the metabolic syndrome
-
批准号:19591045
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:UGI Satoshi
-
依托单位:
海外基金